Cavalier Investments »

Vertex Pharmaceuticals Incorporated shares owned by Cavalier Investments

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Cavalier Investments from 13F filings

Historical chart of Cavalier Investments investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Cavalier Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Cavalier Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8M 6.7k 418.01
2023-09-30 $2.2M 6.2k 347.74
2023-06-30 $2.1M 6.0k 351.91

More positions owned by Cavalier Investments

Vaneck Etf Trust Semiconductr Etf (SMH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Technology (XLK)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Energy (XLE)
Fair Isaac Corporation (FICO)
Booking Holdings (BKNG)
Vanguard World Financials Etf (VFH)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Howmet Aerospace (HWM)
Copart (CPRT)
Regeneron Pharmaceuticals (REGN)

View all positions for Cavalier Investments

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated